ACET Adicet Bio Inc

$ACET Huge upside... The stock is going to fly very soon. Right time to get in . Positive clincal trail. But the prices have fallen. This will bounce in no time... 🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥

$ACET I hate biotech, i bought when they released the positive data 2 weeks ago down over 50%

$ACET One month ago it was $10 a share. Now with a positive clinical trial where should it be. Grossly misunderstood. This will fly in no matter of time. 🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥fly

$ACET Sometimes the market does no read the news and the data, especially as algorithm driven trading cannot understand the nuances. Here the nuance is that the ORR is achieved for 21/22 patients "steroids free", which makes the comparison with other treatments a-symmetric. We shall see whether with a few more days to read and understand, the market corrects its initial view.

$ACET The company has been severely lagging on timely execution, and it is becoming increasingly clear that its regulatory preparations were not sufficiently advanced. Yesterday’s guidance on regulatory interactions was disappointing, suggesting that Q1’27 may be a reasonable timeframe to see FDA meeting minutes confirming the registrational trial details. By then, the company would have only around six months of cash remaining. The RMAT designation should have been secured much earlier and could have helped accelerate the overall development pace. While yesterday’s clinical update exceeded my expectations, the painfully slow execution is increasingly putting the company at risk.

$ACET Looking at this SP action one might think gamma delta caused patients to die. Unbelievable.

$ACET anyone else buying this the last few days? I’ve been buying like crazy, which is either incredibly stupid or incredibly smart. Time will tell.

$ACET all car-t are struggling look at $CRBU it’s done now with discontinuation of its internal CAR-T programs, even other companies are scrapping some of their programs or pivoting like $CLLS , even $CAPR it started a bearish trend.

$ACET for anyone interested, the investor presentation on the Adicet website entitled Prula-cel Clinical Data Update on 9/28 gives a very good overview of where the company is and what advantages their product has over the competition.

$ACET when they released the data 2 weeks ago, they were over 10 dollar per share, now sitting at 4 dollars and not even a bounce at all… how they lost more than half of the value in 2 weeks with 47 million market cap. They don’t have any cash or what?!

$ACET Balance Sheet Total Cash (mrq) 118.19M Total Cash Per Share (mrq) 10.98 Total Debt (mrq) 12.85M Total Debt/Equity (mrq) 10.70% Current Ratio (mrq) 6.71 Book Value Per Share (mrq) 11.16

$ACET got out at huge loss after the pop last year from .70 to 1 dollar when they diluted right after good PR / data set I am so glad I was able to get out before the reverse split I did add on in low .60 too

$ACET best thing to do is move and run for the hills I lost a decent amount in this there lead candidate is first in class car t with no other thing like it and very slim approval chance it’s almost out of money I revisit from time to time and can’t believe it’s back to 3 after reverse

$ACET had a long history with this and sad to say this is a dead end. Nothing near phase 3 and very rare and unique treatment. Cut my loses and moved on idk how they are still listed it’s a very long shot